The Pharmaceutical Export And Packaging Industry

By Author: Laxmi Upasna
Total Articles: 8
Comment this article

The pharmaceutical export company has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Through cost effective manufacturing capabilities and a few loyal customers, the company entered the high margin specialty generic formulations segment. In less than a decade it has evolved into a knowledge driven company manufacturing active pharmaceutical ingredients and formulation products. It is R&D focused and has a multi-product portfolio with manufacturing facilities in several countries. The formulation business is systematically organized with a divisional structure, and has a focused team for key international markets. Leveraging on its large manufacturing infrastructure for APIs and formulations, wide and diversified basket of products and confidence of its customers, it aims to achieve USD 2 billion revenues by 2015-16. A well-integrated company it exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations. Its customers include premium multi-national ...
... companies. With multiple facilities approved by leading regulatory agencies such as USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada and Brazil ANVISA.

Every state in the country requires wholesale pharmaceutical suppliers and the manufacturers to abide by the implementation of environmental regulations as well as the current conservation laws, with the purpose of mitigating the adverse impacts of these products to the environment, particularly during the manufacturing stage. These regulation standards have been created due to the issues related to environmental contamination, particularly within under-developed countries. In addition to those already implemented legislations that pertain to distribution and manufacturing of pharmaceutical products, some pharmaceutical companies today, are starting to observe strict mandatory compliance and strict internal regulations in order for them to achieve the highest ISO certification from International Standards Organization. If you need to look for wholesale pharmaceutical distributors, your first option is to look for them online. But do not just settle with any companies, you first do your preliminary search. Make sure that they are following every local law and legislation with regards to distribution and manufacturing, as well as having the right and proper certification from different agencies and organizations governing their industry. As you look for a pharmaceutical distribution company, you must choose the company that can offer a wide range of safe and quality pharmaceutical products so that you will not need to look for another company and begin your search again. Should you need some specific pharmaceutical products, searching online for a good pharmaceutical distributor whom you know you can trust, is the best way to find a reliable pharmaceutical company. They can offer most pharmaceutical medications along with other important information related to the product as well as to the company who manufactured the drugs.

The size of clinical trial supplies and packaging industry continues to expand, observers say, creating a ripple effect in pharmaceutical packaging. More emphasis is being placed on secondary packaging design to minimize risk of product damage or activation during shipment. Studies are also becoming larger, as regulators encourage the pharmaceutical industry to test a greater number of patients. The challenge is preparing supplies that prompt compliance, as many clinical studies have complex dosing regimens and require packaging components to be flexible and applicable for all study countries. The most common types of packages for clinical trials are blisters, bottles, pouches, syringes and tubes, industry members say. Each may be assembled in different configurations, so as to drive study compliance. Medication adherence is having a substantial impact on the approval criteria for drug candidates, according to published reports. FDA recently provided a draft guidance specifically addressing adherence strategies, including encouraging sponsors to implement adherence practices, such as using smart bottles to monitor medication use. Since pharma companies can control the packaging, as such, it is viewed as a key tool for driving patient adherence.

Author Bio:


For the past 3 years I have been writing informative and high quality articles on pharmaceuticals. In the above article have covered topics such as pharmaceutical export company, wholesale pharmaceutical suppliers, and clinical trial supplies and packaging.